Table 3. Frequencies of KIR-HLA combinations among individuals with symptomatic acute encephalitis and healthy subjects.
| KIR and HLA combinations |
Subjects with acute encephalitis (n: 30) |
Subjects without acute encephalitis (n: 36) |
p | |
|---|---|---|---|---|
| 2DL 2-HLA-C1 (n/%) | 5 (16.6) | 15 (50) | 0.028 | |
| 2DL 3-HLA-C1 (n/%) | 4 (13.3) | 12 (33.3) | 0.059 | |
| 2DS2-HLA-C1 (n/%) | 4 (13.3) | 11 (30.5) | 0.096 | |
| 2DS2-HLA-C2 (n/%) | 1 (3.3) | 2 (5.5) | 0.66 | |
| 2DL2- HLA-C2 (n/%) | 4 (13.3) | 4 (11.1) | 0.78 | |
| 2DS1-HLA-C2 (n/%) | 5 (16.6) | 4 (11.1) | 0.51 | |
| 2DL1-HLA-C1 (n/%) | 6 (20) | 3 (8.3) | 0.16 | |
| 2DL1-HLA-C2 (n/%) | 3 (10) | 4 (11.1) | 0.88 | |
| 3DL1-HLA-Bw4T (n/%) | 9 (30) | 4 (11.1) | 0.055 | |
| 3DS1-HLA-Bw4T (n/%) | 4 (13.3) | 6 (16.6) | 0.70 | |
| 3DS1-HLA-A-BW4 (n/%) | 4 (13.3) | 6 (16.6) | 0.707 | |
| 3DS1-HLA-B-BW4T (n/%) | 4 (13.3) | 6 (16.6) | 0.707 | |
| 3DS1-HLA-B-BW4I (n/%) | 3 (10) | 4 (11.1) | 1.0 | |
| 3DL1-HLA-A-BW4 (n/%) | 4 (13.3) | 3 (8.3) | 0.693 | |
| 3 DL1-HLA-B-BW4T (n/%) | 9 (30) | 4 (11.1) | 0.055 | |
| 3DL1-HLA-B-BW4I (n/%) | 4 (13.3) | 3 (8.3) | 0.693 | |
KIR: Killer-cell immunoglobulin-like receptors; HLA: human leukocyte antigen.